<?xml version="1.0" encoding="UTF-8"?>
<p>Intraventricular transplantation of human UCB‐derived MSCs into extremely premature infants with severe IVH was found to be safe and feasible. This promising therapeutic modality warrants further evaluation for safety and therapeutic efficacy in a larger and well‐controlled prospective phase II study.</p>
